LCN2 and myeloid sarcoma: Among the complex microenvironment in white matter (WM) after SAH, previous work has indicated that lipocalin-2 (LCN2) has a negative effect on remyelination in patients with progressive MS[9] and might represent a biomarker of acute brain injury [10, 11] and a “help-me” signal for repair [12].